Drugs / Omeza skin protectant
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT05921292 | Jul 2022 → Jan 2024 | chronic ulcer of skin | Omeza, LLC | Completed | No outcome recorded |
| Phase 11 trial | ||||||
| Phase 1 | NCT05417425 | Sep 2022 → Oct 2023 | ulcer of lower limbs | Omeza, LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Omeza Skin Protectant | “Omeza® Skin Protectant” NCT05921292 ↗ |
| Route | Topical | “Omeza® Skin Protectant will be applied to the periwound and surrounding intact skin” NCT05921292 ↗ |